Grace Therapeutics
Manufacturing · New Jersey, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2 Tower Center Blvd Ste 1101G, East Brun...Phone Number
(646) 809-6839Website
www.gtrx.comRevenue
-Industry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Grace Therapeutics
Grace Therapeutics is a pharmaceutical company with a focus on rare and orphan diseases. Grace's strategy is to develop novel delivery technologies that dramatically improve the clinical outcomes of drugs previously approved for use in humans. Its selective pipeline screening model supports the development of differentiated products with a unique evidence-based and outcomes-driven value proposition . ITs pipeline consists of three distinct assets all in late stage clinical development for the treatment of Postherpetic Neuralgia, Subarachnoid Hemorrhage, and Ataxia Telangiectasia. The company intend to pursue multiple commercialization options for these products including their proprietary platform technologies for maximum value creation.Explore more
Grace Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Grace Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Grace Therapeutics is spiking on competitors!
Grace Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Grace Therapeutics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Grace Therapeutics has new funding data
Earning: See what the market has to say on Grace Therapeutics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Grace Therapeutics
Product Launch: Get notified when Grace Therapeutics launches new products
Website visits: Recent activity has been detected on your website
Check if Grace Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Grace Therapeutics
Find 2 more new buyers
Compare Similar Companies to Grace Therapeutics
Compare insights from companies similar to Grace Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Grace Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Grace Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Grace Therapeutics.
Grace Therapeutics financials insights
Gather financial insights about Grace Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
2025
Debt
$30M
Grace Therapeutics Tech Stack
A closer look at the technologies used by Grace Therapeutics
Most Recent Scoops
Earnings
Earnings, Finance
Project
Product Development, Product Management, Intellectual Property, Legal Affairs, Pharmaceuticals
Earnings
Earnings, Finance
Earnings
Earnings
Earnings
Earnings, Finance
Grace Therapeutics News & Media
GRCE INVESTOR ALERT: Holzer & Holzer, LLC Investigation of Grace Therapeutics, Inc.
ATLANTA, June 03, 2026 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Grace Therapeutics, Inc. (“Grace Therapeutics” or the “Company”) (NASDAQ: GRCE) complied with federal securities laws. On April 23, 2026, Grace Therapeutics announced the FDA issued a Complete Response Letter (“CRL”) for the Company’s New Drug Application for GTx-104 revealing that the CRL referenced certain items “related to leachables data for product packaging, non-clinical product toxicology risk assessmINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Grace Therapeutics, Inc. - GRCE
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Grace Therapeutics, Inc. ("Grace" or the "Company") (NASDAQ: GRCE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...Grace Therapeutics Announces Abstract Highlighting STRIVE-ON Phase 3 Trial Results Accepted for Presentation at AAN 2026
PRINCETON, N.J., April 14, 2026 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage, novel, injectable formulation of nimodipine being developed for intravenous infusion to address significant unmet medical needs in aneurysmal subarachnoid hemorrhage (aSAH) patients, today announced that an abstract highlighting the results from the Company’s STRIVE-ON Phase 3 Safety Trial has been acGrace Therapeutics to Present Data on the Unmet Medical Needs and Potential Benefits of GTx-104 in the Treatment of aSAH at Upcoming Medical Conferences
PRINCETON, N.J., March 19, 2026 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage, novel, injectable formulation of nimodipine being developed for intravenous infusion to address significant unmet medical needs in aneurysmal subarachnoid hemorrhage (aSAH) patients, today announced that abstracts discussing the unmet medical needs and the potential benefits of GTx-104 have been accep
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Grace Therapeutics
Sign Up For FreeTo access detailed company insights
Grace Therapeutics is a pharmaceutical company with a focus on rare and orphan diseases. Grace's strategy is to develop novel delivery technologies that dramatically improve the clinical outcomes of drugs previously approved for use in humans. Its selective pipeline screening model supports the development of differentiated products with a unique e... Read More
